Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 1, 2008, Pages 65-71

  Smits, A ^a   Westerberg, E ^a   Ribom, D ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

11C methionine; Low grade glioma; Positron emission tomography; Prognostic factors; Survival

Indexed keywords

METHIONINE C 11; CARBON; DIAGNOSTIC AGENT; METHIONINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; GLIOMA; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; CHEMISTRY; MEDICAL SOCIETY; METABOLISM; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE PERIOD; RISK; SCINTISCANNING; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; CARBON RADIOISOTOPES; GLIOMA; HUMANS; METHIONINE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; SOCIETIES, MEDICAL; SURVIVAL RATE;

EID: 36849026647     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0531-1     Document Type: Article

References (25)

1. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215-25.
2. Davis FG, Preston-Martin S. Epidemiology. Incidence and survival. In: Bigner DD, McLendon RE, Bruner JM, editors. Russell & Rubinstein's pathology of tumors of the nervous system. London: Arnold; 1998. p. 135-48.
3. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol 2005;109:93-8.
4. Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 2001;95:735-45.
5. Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996;36:549-56.
6. Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 2002;52:316-24.
7. Shaw E, Arusell R, Scheithauer B, ÓFallon J, ÓNeill B, Dinapoli R, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002;20:2267-76.
8. Pignatti F, van den Bent M, Curran D, Debruyne C., Sylvester R, Therasse P, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002;20:2076-84.
9. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, et al. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. J Neurosurg 2006;104:238-53.
10. Herholz K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus RI, et al. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998;50:1316-22.
11. De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, et al. Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 2001;95:746-50.
12. Ribom D, Eriksson A, Hartman M, Engler H, Nilsson A, Langstrom B, et al. Positron emission tomography 11C-methionine and survival in patients with low-grade gliomas. Cancer 2001;92:1541-9.
13. Kaschten B, Stevenaert A, Sadzot B, Deprez M, Dequeldre C, Del Fiore G, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 1998;39:778-85.
14. Ribom D, Engler H, Blomquist E, Smits A. Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas. Eur J Nucl Med 2002;29:632-40.
15. Bergstrom M, Lundqvist H, Ericson K, Lilja A, Johnstrom P, Langstrom B, et al. Comparison of the accumulation kinetics of L-(methyl-11C)-methionine and D-(methyl-11C)-methionine in brain tumors studied with positron emission tomography. Acta Radiol 1987;28:225-9.
16. Berger MS, Deliganis AV, Dobbins J, Keles GE. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 1994;74:1784-91.
17. Armstrong CL, Hunter JV, Ledakis GE, Cohen B, Tallent EM, Goldstein BH, et al. Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology 2002;59:40-8.
18. Olson JD, Riedel E, DeAngelis LM. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 2000;54:1442-8.
19. Surma-aho O, Niemela M, Vilkki J, Kouri M, Brander A, Salonen O, et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology 2001;56:1285-90.
20. Postma TJ, Klein M, Verstappen CC, Bromberg JE, Swennen M, Langendijk JA, et al. Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology 2002;59:121-3.
21. Stupp R, Janzer RC, Hegi ME, Villemure JG, Mirimanoff RO. Prognostic factors for low-grade gliomas. Semin Oncol 2003;30:23-8.
22. Daumas-Duport C. Histological grading of gliomas. Curr Opin Neurol Neurosurg 1992;5:924-31.
23. Bell D, Grant R, Collie D, Walker M, Whittle IR. How well do radiologists diagnose intracerebral tumour histology on CT? Findings from a prospective multicentre study. Br J Neurosurg 2002;16:573-7.
24. Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, et al. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 1999;45:923-9.
25. van den Bent MJ, Stupp R, Brandes AA, Lacombe D. Current and future trials of the EORTC brain tumor group. Onkologie 2004;27:246-50.